CPT code 85280: Factor XII, hageman factor activity2026 Medicare lab fee · Clinical Laboratory Fee Schedule
Measures factor XII in a coagulation workup, often when an isolated prolonged activated partial thromboplastin time needs evaluation.
Medicare pays $19.35 for 85280 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$19.35
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2020
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 8 sections
What 85280 covers
This assay measures coagulation factor XII, also called Hageman factor, in plasma. It is commonly ordered by hematology and other clinicians when evaluating an isolated prolonged activated partial thromboplastin time or investigating a suspected contact-pathway factor deficiency. Factor XII deficiency can prolong clotting tests without typically causing a bleeding tendency, so the result helps distinguish laboratory abnormalities from bleeding disorders. A coagulation laboratory performs the assay and reports the factor XII result.
Report 85280 for the factor XII measurement, not for testing another coagulation factor in the same workup. Medicare pays it through the CLFS, with one national amount in every locality and no office-versus-facility difference; the 2026 national amount is $19.35, unchanged since 2020. The test is excluded from the physician fee schedule and paid only through the CLFS.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 85280
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 85280. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Excluded from the physician fee schedule
The physician fee schedule lists 85280 with status X (excluded by statute), so the test itself is paid only from the CLFS.
85280 on the lab fee schedule since 2020
85280 · CLFS 2026 Q4 (current)
$19.35
Unchanged since Jan 1, 2020
27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.
85280 compared with similar tests
- 85270Factor XI assayFactor XI (PTA)$17.90
- Use 85280 for factor XII and 85270 for factor XI. Both may be evaluated in a prolonged activated partial thromboplastin time workup, but they identify different factor measurements.
- 85290Factor XIII testFibrin-stabilizing factor$16.34
- 85280 measures factor XII; 85290 measures factor XIII. Select the code for the factor assayed, rather than treating the factor tests as interchangeable.
- 85292Prekallikrein assayFletcher factor measurement$18.93
- 85280 is the factor XII assay, while 85292 measures Fletcher factor (prekallikrein). These are distinct contact-pathway tests.
85280 billing questions
When is factor XII testing different from factor XI testing?
Report 85280 when the laboratory measures factor XII. Use 85270 when the assay measures factor XI; the factors are separate tests even when both are considered in a prolonged clotting-time workup.
Does 85280 include testing other coagulation factors?
No. It represents the factor XII measurement; report a separately performed factor assay under the code for that specific factor.
Is modifier 26 appropriate for the physician's interpretation?
No. Medicare pays this test only through the CLFS; it is excluded from the physician fee schedule.
How does Medicare price 85280?
The CLFS sets one national payment amount for the code, applied across localities without an office or facility difference. The amount has remained unchanged since 2020.
How should the result be interpreted in a prolonged clotting-time workup?
Factor XII deficiency can prolong the activated partial thromboplastin time without typically producing a bleeding tendency. Interpret the result in the context of the clinical evaluation and other factor testing.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 85280 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist